Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 100 results found. Search for [ indian pharmaceutical alliance ]

Results 1 to 21 of 100
PB Jayakumar
New Delhi, July 22, 2019
Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years


Joe C Mathew
New Delhi, July 22, 2019
The India-Japan economic partnership is going way beyond select sectors. The growing trade and industry linkages are making Japan an integral part of India's development journey


E Kumar Sharma
New Delhi, June 20, 2019
The Indian pharmaceutical industry players believe it is high time for the government to articulate a clear blueprint to support manufacturing and research


E Kumar Sharma
New Delhi, June 10, 2019
Drug regulatory reforms in China have turned the heat on the Indian pharmaceutical industry and raised the cost of bulk drugs. But some firms have managed to turn the crisis into an opportunity by filling in the space left by the Chinese.


BusinessToday.In
May 9, 2019
In as many as 666 cases, pharma companies are yet to disgorge excess profits accrued by overcharging customers under the Drug Prices Control Orders. The DoP has now made a one-time settlement offer on their total outstanding dues, provided they collectively cough up Rs 3,501 crore and drop their lawsuits


PTI
April 9, 2019



PB Jayakumar
NA, March 18, 2019
Indian pharma companies need to move fast on THE digital highway to stay relevant in the future.


E Kumar Sharma
February 22, 2019
D G Shah had a larger imprint on the pharma industry than what his job title -- secretary general of the Indian Pharmaceutical Alliance (IPA) -- could convey.


PB Jayakumar
February 22, 2019
An expert on IP rights and international trade relations related to pharmaceuticals, Shah had fought for Indian generic industry in several WTO and many other international pharma and IPR deliberations.


E Kumar Sharma
New Delhi, February 19, 2019
DG Shah, Secretary General of the Indian Pharmaceutical Alliance, sees problems on three fronts: pricing, regulatory and exports.


PTI
December 31, 2018



PB Jayakumar
New Delhi, November 26, 2018
Market changes and increased regulatory oversight in the US have hurt Lupin, but India's third-biggest drug maker is making efforts to come back.


PB Jayakumar
New Delhi, October 29, 2018
A big transformation is happening in the global generic pharmaceutical industry. As a result, stocks of most major drug companies have done badly in the past one year.


E Kumar Sharma
New Delhi, June 12, 2018
Indian pharma is on edge with an expected pharma pricing overhaul, but nothing is known yet on the shape of things to come.


BusinessToday.In
June 10, 2018
During the summit, India signed various agreements with the member countries including host nation China. Prime Minister Modi held nearly half a dozen bilateral meetings with leaders of other SCO countries.


PB Jayakumar
New Delhi, March 7, 2018
The Indian pharmaceutical industry, earlier reeling under the regulatory scanner of the USFDA, is learning from its mistakes.


PB Jayakumar
New Delhi, March 5, 2018
Out of the 192 inspections held by the US FDA in India in 2017, only eight were referred for Official Action indicated (OAI) or found out objectionable conditions at the audit site


E Kumar Sharma
New Delhi, February 1, 2018
The measures announced in the budget could trigger a rise in demand for medicines but those within the Indian pharma feel this alone may not help.


E Kumar Sharma
New Delhi, January 12, 2018
Many companies, with some leading players, are already coping with challenges around price erosion in generics, erosion of base business resulting from new competition and buyer consolidation in their biggest global market, the US.


PTI
December 27, 2017



PAGES 1 OF 5  12345